Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Proto Labs (PRLB) EBT Margin (2016 - 2025)

Proto Labs' EBT Margin history spans 14 years, with the latest figure at 5.97% for Q4 2025.

  • For Q4 2025, EBT Margin rose 620.0% year-over-year to 5.97%; the TTM value through Dec 2025 reached 5.83%, up 90.0%, while the annual FY2025 figure was 5.83%, 90.0% up from the prior year.
  • EBT Margin for Q4 2025 was 5.97% at Proto Labs, down from 7.57% in the prior quarter.
  • Across five years, EBT Margin topped out at 13.2% in Q2 2021 and bottomed at 100.95% in Q4 2022.
  • The 5-year median for EBT Margin is 5.75% (2021), against an average of 0.58%.
  • The largest annual shift saw EBT Margin crashed -11141bps in 2022 before it soared 10890bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 10.46% in 2021, then plummeted by -1065bps to 100.95% in 2022, then skyrocketed by 108bps to 7.95% in 2023, then plummeted by -103bps to 0.23% in 2024, then soared by 2679bps to 5.97% in 2025.
  • Per Business Quant, the three most recent readings for PRLB's EBT Margin are 5.97% (Q4 2025), 7.57% (Q3 2025), and 4.94% (Q2 2025).